NASDAQ:PRPH
ProPhase Labs Stock News
$5.03
-0.0800 (-1.57%)
At Close: May 17, 2024
ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results
09:05am, Wednesday, 31'st Mar 2021
Recent Acquisition of Digital COVID-19 Vaccination and Testing “Passport” Transforms the Company's Portal Into a Universal Digital Certificate Solution and Uniquely Positions Company for Re-Openin
PRPH Stock Price Increased Over 10% Pre-Market: Why It Happened
06:17am, Wednesday, 31'st Mar 2021
The stock price of ProPhase Labs, Inc. (NASDAQ: PRPH) increased by over 10% pre-market. This is why it happened.
ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
05:10pm, Tuesday, 30'th Mar 2021
New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021 a
With Pivot To COVID-19 Testing, ProPhase Labs Could Greatly Reward Shareholders
09:47am, Wednesday, 17'th Feb 2021
With Pivot To COVID-19 Testing, ProPhase Labs Could Greatly Reward Shareholders
ProPhase Labs: Meet the team that's looking to revolutionize coronavirus testing
02:36pm, Thursday, 11'th Feb 2021
ProPhase Labs, Inc (NASDAQ:PRPH) is one of three emerging companies that will present at Proactive's virtual investor conference on Tuesday, February 16. Hosted by Proactive's Christine Corrado, the e
Company Integrates Spectrum Solutions™ SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations
ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
08:30am, Monday, 01'st Feb 2021
Company to Host Business Update Shareholder's Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
08:30am, Friday, 29'th Jan 2021
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day –
ProPhase Labs, Inc. Announces Closing of Public Offering
04:30pm, Thursday, 21'st Jan 2021
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced pub
ProPhase Labs Announces Pricing of Public Offering of Common Stock
09:50pm, Monday, 18'th Jan 2021
GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public offer
ProPhase Labs Announces Proposed Public Offering of Common Stock
05:21pm, Friday, 15'th Jan 2021
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed underwritt
Company Exceeding Near Term Goals & Expands 2021 Testing Capacity
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
12:10pm, Tuesday, 05'th Jan 2021
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive secur
ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
04:15pm, Tuesday, 08'th Dec 2020
Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day
